Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    Ruby Khatun Khatun
    Ruby Khatun Khatun
      • Home
      • Ruby Khatun Khatun

      Articles By : Ruby Khatun Khatun

      Gap in regulating biotech drug copies prompts WHO to step in

      Gap in regulating biotech drug copies prompts WHO to step in

      Ruby Khatun Khatun3 Jun 2018 10:30 AM IST
      LONDON: Cut-price copies of expensive biotech drugs promise to slash the cost of treating serious diseases, including cancer, in rich and poor...
      Lupin appoints Nicholas Hart as head of specialty business in US

      Lupin appoints Nicholas Hart as head of specialty business in US

      Ruby Khatun Khatun3 Jun 2018 10:15 AM IST
      New Delhi: Drug maker Lupin said it has appointed Nicholas Hart as President of its Specialty business in the US.Hart will lead the specialty...
      Apollo Hospitals Q4 net dips 43 percent to Rs 36 crore

      Apollo Hospitals Q4 net dips 43 percent to Rs 36 crore

      Ruby Khatun Khatun3 Jun 2018 10:00 AM IST
      New Delhi: Apollo Hospitals reported 42.6 percent decline in its consolidated profit after tax at Rs 35.7 crore for the fourth quarter ended March...
      Allergan to sell womens health, infectious disease units

      Allergan to sell women's health, infectious disease units

      Ruby Khatun Khatun3 Jun 2018 9:45 AM IST
      NEW YORK: Drugmaker Allergan Plc said it plans to sell two of its smaller businesses, the women’s health, and infectious disease units, as Chief...
      AstraZeneca drug Fasenra fails to achieve main goal in COPD trial

      AstraZeneca drug Fasenra fails to achieve main goal in COPD trial

      Ruby Khatun Khatun3 Jun 2018 9:30 AM IST
      AstraZeneca’s first respiratory biological medicine Fasenra failed to meet its main target in a second clinical trial treating patients with moderate...
      Fortis Healthcare appoints Ravi Rajagopal as chairman

      Fortis Healthcare appoints Ravi Rajagopal as chairman

      Ruby Khatun Khatun3 Jun 2018 9:30 AM IST
      New Delhi: Fortis Healthcare said it has appointed Ravi Rajagopal as the chairman of the company’s board with immediate effect.Rajagopal (63), a...
      Fortis board shortlists four bidders for takeover process

      Fortis board shortlists four bidders for takeover process

      Ruby Khatun Khatun2 Jun 2018 11:30 AM IST
      New Delhi: Fortis Healthcare said it has shortlisted four entities -- the Munjal-Burman combine, Manipal-TPG consortium, Malaysia's IHH Healthcare...
      Lupin launches oral antibiotic Solosec in US

      Lupin launches oral antibiotic Solosec in US

      Ruby Khatun Khatun2 Jun 2018 10:30 AM IST
      New Delhi: Drug major Lupin said it has launched Solosec, an oral antibiotic used in treating bacterial vaginosis (BV) in women, in the US market.The...
      Granules Indias US arm launches generic Methergine tablets in US market

      Granules India's US arm launches generic Methergine tablets in US market

      Ruby Khatun Khatun2 Jun 2018 10:15 AM IST
      New Delhi: Granules India Ltd said its US subsidiary has launched the generic version of Methergine (Methylergonovine Maleate) tablets, in partnership...
      AstraZeneca expands its GMD Centre in India

      AstraZeneca expands its GMD Centre in India

      Ruby Khatun Khatun2 Jun 2018 10:00 AM IST
      Global science-led biopharmaceutical company AstraZeneca officially opened its new Global Medicines Development (GMD) Centre in Bengaluru, India.This...
      Cytecare Hospital raises 31 million dollar from Goldman Sachs, others

      Cytecare Hospital raises 31 million dollar from Goldman Sachs, others

      Ruby Khatun Khatun2 Jun 2018 10:00 AM IST
      Bengaluru-based cancer care provider Cytecare Hospital said it has raised USD 31 million, including USD 5 million from Wall Street bank Goldman Sachs'...
      Pfizer receives FDA breakthrough therapy designation for XALKORI

      Pfizer receives FDA breakthrough therapy designation for XALKORI

      Ruby Khatun Khatun2 Jun 2018 9:45 AM IST
      NEW YORK: Pfizer Inc. announced that the U.S. Food and Drug Administration (FDA) granted Breakthrough Therapy designation for XALKORI® (crizotinib)...
      PrevNext

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok